Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV)

被引：0
|
作者：
Lucia Masarova
C. Cameron Yin
Jorge E. Cortes
Marina Konopleva
Gautam Borthakur
Kate J. Newberry
Hagop M. Kantarjian
Carlos E. Bueso-Ramos
Srdan Verstovsek
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Leukemia
[2] The University of Texas MD Anderson Cancer Center,Department of Hematopathology
来源：
Experimental Hematology & Oncology | / 6卷
关键词：
Essential thrombocythemia; Polycythemia vera; Pegylated interferon alfa-2a; Histomorphological response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV)
    Masarova, Lucia
    Yin, C. Cameron
    Cortes, Jorge E.
    Konopleva, Marina
    Borthakur, Gautam
    Newberry, Kate J.
    Kantarjian, Hagop M.
    Bueso-Ramos, Carlos E.
    Verstovsek, Srdan
    [J]. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2017, 6
  • [2] Histomorphological Responses after Therapy with Pegylated Interferon Alpha-2a in Patients with Essential Thrombocythemia (ET) and Polycythemia Vera (PV)
    Masarova, Lucia
    Yin, C. Cameron
    Cortes, Jorge E.
    Konopleva, Marina
    Borthakur, Gautam
    Newberry, Kate J.
    Kantarjian, Hagop M.
    Bueso-Ramos, Carlos E.
    Verstovsek, Srdan
    [J]. BLOOD, 2016, 128 (22)
  • [3] Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon α-2a
    Quintas-Cardama, Alfonso
    Abdel-Wahab, Omar
    Manshouri, Taghi
    Kilpivaara, Outi
    Cortes, Jorge
    Roupie, Anne-Laure
    Zhang, Su-Jiang
    Harris, David
    Estrov, Zeev
    Kantarjian, Hagop
    Levine, Ross L.
    Verstovsek, Srdan
    [J]. BLOOD, 2013, 122 (06) : 893 - 901
  • [4] Treatment with pegylated Interferon-Atfa-2A (PEG-IFN-Aα-2A; PEGASYS™) for patients with essential thrombocythemia (ET) and polycythemia vera (PV).
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop
    Giles, Francis
    Cortes, Jorge
    Richie, Mary Ann
    Borthakur, Gautam
    Verstovsek, Srdan
    [J]. BLOOD, 2006, 108 (11) : 307B - 307B
  • [5] Use of pegylated interferon in young patients with polycythemia vera and essential thrombocythemia
    Kucine, Nicole
    Bergmann, Shayla
    Krichevsky, Spencer
    Jones, Devin
    Rytting, Michael
    Jain, Juhi
    Bennett, Carolyn M.
    Resar, Linda M. S.
    Mascarenhas, John
    Verstovsek, Srdan
    Hoffman, Ronald
    [J]. PEDIATRIC BLOOD & CANCER, 2021, 68 (03)
  • [6] Pegylated Interferon-ALFA-2A (PEG-IFN-α-2A; PEGASYS) Therapy Renders High Clinical and Molecular Response Rates in Patients with Essential Thrombocythemia (ET) and Polycythemia VERA (PV)
    Quintas-Cardania, Alfonso
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Richie, Marie Ann
    Borthakur, Gautam
    Verstovsek, Srdan
    [J]. BLOOD, 2008, 112 (11) : 246 - 246
  • [7] Efficiency of interferon therapy in patients with essential thrombocythemia or polycythemia vera
    Sokolova, M. A.
    Turkina, A. G.
    Melikian, A. L.
    Sudarikov, A. B.
    Treglazova, S. A.
    Shukhov, O. A.
    Gemdzhian, E. G.
    Abdullaev, A. O.
    Kovrigina, A. M.
    Misyurin, A. V.
    Pliskunova, Yu. V.
    Ivanova, V. L.
    Moiseeva, T. N.
    [J]. TERAPEVTICHESKII ARKHIV, 2016, 88 (12): : 69 - 77
  • [8] Pegylated interferon-alfa-2a (PEG-IFN-α-2A; PEGASYSTM) for essential thrombocythemia (ET) and polycythemia vera (PV):: An update of an ongoing phase II study
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Richie, Marie Ann
    Borthakur, Gautam
    Verstovsek, Srdan
    [J]. BLOOD, 2007, 110 (11) : 1036A - 1037A
  • [9] Interferon-α therapy in polycythemia vera and essential thrombocythemia
    Elliott, MA
    Tefferi, A
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1997, 23 (05): : 463 - 472
  • [10] UNUSUAL VEIN THROMBOSIS IN PATIENTS WITH POLYCYTHEMIA VERA (PV) AND ESSENTIAL THROMBOCYTHEMIA (ET)
    Randi, M. L.
    Scapin, M.
    Tezza, E.
    Carideo, N.
    Bertozzi, I.
    Duner, E.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 60 - 60
12345